Dalton Pharma Services, a contract service provider of chemistry, drug development, and manufacturing services, based in North York, Ontario, Canada, has signed a drug development and manufacturing services agreement with Cerium Pharmaceuticals, an emerging biopharmaceutical company based in Gaithersburg, Maryland to support Cerium’s drug-development program.

Dalton will provide formulation development, cGMP liquid filling, analytical method validation, quality control release testing, and ICH stability services. Cerium is focused on drug development for treating rare diseases.

Source: Dalton Pharma Services